Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지

Application of Systems Biology to Traditional Korean Medicine

시스템생물학의 한의학적 응용

  • Park, Yeongchul (GLP Center, Catholic University of Daegu) ;
  • Lee, Sundong (Dept. of Preventive Korean Medicine, School of Korean Medicine, Sangji University)
  • 박영철 (대구가톨릭대학교 GLP센터) ;
  • 이선동 (상지대학교 한의과대학 예방의학교실)
  • Received : 2016.03.03
  • Accepted : 2016.04.19
  • Published : 2016.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

In Korea and China, traditional medicine's holistic approaches, based on the views of whole-body and whole-person, have been applied to make the solution of health problem. However, these holistic approaches of traditional korea or chinese medicine have been limited in interpreting their theories in a view of modern scientific aspects of medicine. This limitation seems to be mainly due to the reductionism approaches of modern scientific medicine. Traditionally, science has taken a reductionism approach; dissecting biological systems into their constituent parts and studying them in isolation. However, systems biology based on omics technologies is providing a new thought and method for traditional medicine's research and interpretation. Systems biology uses integrity study as the characteristic and bioinformatic technology as the key method for connecting reductionism and holism. Therefore, it has much in common with the theory of traditional medicine. It was reviewed that how systems biology is applied to traditional medicine in Korea and China. Also it was suggested that more future researches on interpretation between traditional medicine and systems biology must be focused on personalized medicine since systems biology will have a major impact on future personalized therapeutic approaches.

Keywords

References

  1. Liu X, Wu WY, Jiang BH, Yang M, De-An Guo DA. Pharmacological tools for the development of traditional Chinese medicine. Trends in Pharmacological Sciences. 2013; 34(11):620-628. https://doi.org/10.1016/j.tips.2013.09.004
  2. Li Q, Weina P. Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria. Pharmaceuticals. 2010;3(7):2322-2332. https://doi.org/10.3390/ph3072322
  3. Tu YY, Ni MY, Zhong YR, Li LN, Cui SL, Zhang MQ, Wang XZ, Liang XT. Studies on the constituents of Artemisia annua L. Acta Pharm. Sin. 1981;16:366-370.
  4. Anon. Marketing of new drug from Tianjing TASLY Pharma. Monthly Information on Traditional Chinese Medicine. 2003;15:0304-1502.
  5. Li YG, Song L, Liu M, Hu ZB, Wang ZT. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). J. Chromatogr. A 2009;1216(11):1941-1953. https://doi.org/10.1016/j.chroma.2008.12.032
  6. Zhang A, Sun H, Wang P, Han Y, Wang X. Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach. Complementary Therapies in Medicine. 2012;20:93-99 https://doi.org/10.1016/j.ctim.2011.10.007
  7. Cheng F, Wang X, Song W, Lu Y, Li X, Zhang H, Wang Q. Biologic basis of TCM syndromes and the standardization of syndrome classification. Journal of Traditional Chinese Medical Sciences. 2014;1:92-97. https://doi.org/10.1016/j.jtcms.2014.09.005
  8. 손인철. 한의학에서의 생명관. 원불교사상과 종교문화. 2010;45(특집):119-161.
  9. 백유상. 한의학 정체성 논의에 대한 연구-원전학을 중심으로. J. Oriental Medical Classics. 2010;23(5):123-132.
  10. 정지연, 황금숙, 손인철. 한의학의 과학적 연구를 위한 대사체학(Metabolomics)에 대한 고찰. 경락경혈학회지 2008;4:147-166.
  11. Science Times. "한의학, 증거에 기반하는 학문 돼야" 2009.04.30
  12. Crick F. Central dogma of molecular biology. Nature. 1970;227(5258): 561-563. https://doi.org/10.1038/227561a0
  13. Kandal R, Saviola B, Felton J, The era of 'omics unlimited. Biotechniques. 2009;46:351-355. https://doi.org/10.2144/000113137
  14. Snoep JL. Westerhoff HV. Alberghina L. Systems Biology: Definitions and Perspectives. Topics in Current Genetics(Berlin: Springer-Verlag). 2004;13:13-30.
  15. Chen L, Wang R, Zhang XS. Biomolecular Networks: Methods and Applications in Systems Biology. John Wiley & Sons, Hoboken. New Jersey. 2009.
  16. Guest Editor's Introduction. Systems biology with omics data. Methods. 2014;67: 267-268. https://doi.org/10.1016/j.ymeth.2014.05.005
  17. Liu X, Wu WY, Jiang BH, Yang M, and Guo DA. Pharmacological tools for the development of traditional Chinese medicine. Trends in Pharmacological Sciences. 2013;34(11):620-628. https://doi.org/10.1016/j.tips.2013.09.004
  18. Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese Journal of Natural Medicines. 2013;11(2):0110-0120. https://doi.org/10.1016/S1875-5364(13)60037-0
  19. 조광현. 시스템생물학: 생체네트워크의 동역학에 대한 새로운 고찰. 전기의 세계. 2010;59(3):27-31.
  20. Information theory in systems biology. Part II: protein-proteininteraction and signaling networks. Seminars in Cell & Developmental Biology. In Press, Corrected Proof, Available online. 2015.
  21. Iglesias RA. Systems biology: the role of engineering in the reverse engineeringof biological signaling. Cells. 2013;2(2):393-413. https://doi.org/10.3390/cells2020393
  22. 이민영, 유창규, 이인범. 생물시스템의 네트워크 모델링과 시스템즈 생물학. 제어.자동화.시스템공학회지. 2005;11(3):34-37.
  23. WHO. "WHO International Standard Terminologieson Traditional Medicine in The Western Pacific Region". 2007. Available from : URL : http://www.who.int.
  24. Lee TG, Lee SK, Choe BK, Song IB. A Study on the Prevalences of Chronic Diseases according to Sasang Constitution at a Health Examination Center. J Sasang Constitute Med. 2005;17(2):32-45.
  25. Robinson SW, Fernandes M, Husi H. Current advances in systems and integrative biology. Computational and Structural Biotechnology Journal. 2014;11:35-46. https://doi.org/10.1016/j.csbj.2014.08.007
  26. Wei S, Ye T, Tong R, Zhiqiang G. Genotyping and quantification techniques for singlenucleotide polym orphism s. Trends in Analytical Chemistry. 2015;69:1-13. https://doi.org/10.1016/j.trac.2015.03.008
  27. Giacomini KM, Krauss RM, Roden DM, Eichelbaum M, Hayden MR, Nakamura Y. When good drugs go bad. [J] Nature. 2007; 446(7139):975-977. https://doi.org/10.1038/446975a
  28. Hedrick P. Genetics of Populations. Jones & Bartlett Learning. 2011;104. ISBN 978-0-7637-5737-3.
  29. 이수경, 이성진. 사상체질의 Cholecystokinin 유전자 단일염기다형성 연구. 대한한의학회지. 2004; 25(3):105-110.
  30. 송일병, 이수경. 사상체질의 유전적 다형성 연구- MTHFR의 단일염기다형성을 중심으로 - 사상체질의학회지. 2001;13(2):177-181.
  31. Cha SW, Koo I, Park BL, Jeong SK, Choi SM, Kim KS, Shin HD, and Kim JY. Genetic Effects of FTO and MC4R Polymorphisms on Body Mass in Constitutional Types. Evidence-Based Complementary and Alternative Medicine. 2011;1-7.
  32. http://ko.wikipedia.org/; 위키백과-한증 및 열증
  33. 금진호. 팔강변증에 대한 비교 연구 -장개빈, 정국팽, 강함돈을 중심으로- 대한한의학원전학회. 2013; 26(2):47-59.
  34. 김성훈, 박종오. 상한 온병의 팔강변증(八綱辨證) 분류체계에 관한 연구. 대전대학교 한의학연구소논문집. 1998; 6(2):351-381.
  35. Kim Jin-ho. A Comparative Research of Eight Principle Pattern Identification - based on Zhang Jie-Bin, Cheng Guo-Peng, and Jiang Han-Tun. - J. Oriental medical Classics. 2013:25(2):47-59.
  36. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuroendocrine-immune network. IET Systems Biology. 2007;1(1):51-60. https://doi.org/10.1049/iet-syb:20060032
  37. ONIM 데이터베이스(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM)
  38. McGettigan PA. Transcriptomics in the RNAseq era Paul A McGettigan. Current Opinion in Chemical Biology. 2013;17:4-11. https://doi.org/10.1016/j.cbpa.2012.12.008
  39. Yan SK, Liu RH, Jin HZ, Liu XR, Ye J, Shan L, Zhang WD. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives. Chinese Journal of Natural Medicines. 2015;13(1):3-21. https://doi.org/10.1016/S1875-5364(15)60002-4
  40. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ, Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866-1870. https://doi.org/10.1126/science.294.5548.1866
  41. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol. Rev. 2006;58:798-836. https://doi.org/10.1124/pr.58.4.10
  42. Li L, Bonneton F, Chen YX, Laudet V. Botanical compounds and their regulation of nuclear receptor action: The case of traditional Chinese medicine. Molecular and Cellular Endocrinology. 2015;401:221-237. https://doi.org/10.1016/j.mce.2014.10.028
  43. Sladek FM. What are nuclear receptor ligands? Mol. Cell. Endocrinol. 2010;334:3-13.
  44. Gao J, Xie W. Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol. Sci. 2012;33:552-558. https://doi.org/10.1016/j.tips.2012.07.003
  45. Pearen MA, Muscat GE, Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 2010; 24:1891-1903. https://doi.org/10.1210/me.2010-0015
  46. Calkin AC, Tontonoz P, Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 2012;13:213-224. https://doi.org/10.1038/nrm3312
  47. Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y. Frank J. Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002; 296:1703-1706. https://doi.org/10.1126/science.1072891
  48. James P. "Protein identification in the postgenome era: the rapid rise of proteomics". Quarterly reviews of biophysics. 1997;30(4): 279-331. https://doi.org/10.1017/S0033583597003399
  49. 주현, 한진. 프로테오믹스 : 단백질에 대한 이해 및 기능 해석의 새로운 접근과 응용. 범문사. 2004.
  50. Zhang A, Sun H, Yuan Y, Sun W, Jiao G, Wang X. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen- Hao-Tang based on its active constituents, Fitoterapia. 2011;82:1160-1168. https://doi.org/10.1016/j.fitote.2011.07.014
  51. Sun H, Zhang A, Yan G, Han Y, Sun W, Ye Y, Wang X. Proteomics study on the hepatoprotective effects of traditional Chinese medicineformulae Yin-Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2013;75:173-179. https://doi.org/10.1016/j.jpba.2012.11.025
  52. Nicholson JK. Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2006;2(1):52.
  53. Jordan KW, Nordenstam J, Lauwers GY, Rothenberger DA, Alavi K, Garwood M, Cheng LL. Metabolomic Characterization of Human Rectal Adenocarcinoma with Intact Tissue Magnetic Resonance Spectroscopy. Diseases of the Colon & Rectum. 2009;52 (3):520-525. https://doi.org/10.1007/DCR.0b013e31819c9a2c
  54. Kraly JR, Holcomb RE, Guan Q, Henry CS. Review: Microfluidic applications in metabolomics and metabolic profiling. Analytica Chimica Acta. 2009;653:23-35. https://doi.org/10.1016/j.aca.2009.08.037
  55. Naz S, Vallejo M, Garcia A, Barbas C. Method validation strategies involved in non-targeted metabolomics. Journal of Chromatography A. 2014;1353:99-105. https://doi.org/10.1016/j.chroma.2014.04.071
  56. 김소현, 양승옥, 김경헌, 김영석, 유광현, 윤영란, 이동호, 이충환, 황금숙, 정면우, 최기환, 최형균. 대사체학의 연구 동향, 응용 및 국내 연구 활성화 방안. KSBB Journal. 2009;24(2):113-121.
  57. Gerdes S, Mrowietz U. Comorbidities and psoriasis. Impact on clinical practice. Hautarzt. 2012;63(3):202-213. https://doi.org/10.1007/s00105-011-2230-x
  58. Lu C, Deng J, Li L, Wang D, Li G. Application of metabolomics on diagnosis and treatment of patients with psoriasis in traditional Chinese medicine. Biochimica et Biophysica Acta. 2014;1844:280-288. https://doi.org/10.1016/j.bbapap.2013.05.019
  59. Marr K. A Glimpse Into Personalized Medicine of the Future. The Washington Post. Archived URL: http://www.webcitation.org/5lBDFAeE7. November 10, 2009.
  60. Owen K. Davis, Zev Rosenwaks. Personalized medicine or "one size fits all?" Fertility and Sterility. 2013;101(4):922-923. https://doi.org/10.1016/j.fertnstert.2014.02.030
  61. 1000 Genomes. A deep catalog of human genetic variation. Available at: http://www.1000genomes.org/about. Accessed November 30, 2012.
  62. Genomes Project Committee. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073. https://doi.org/10.1038/nature09534
  63. Genomes Project Committee; Abecasis GR, Auton A, Brooks LD et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65. https://doi.org/10.1038/nature11632
  64. Bartfai T, Lees GL. Chapter 09 - Personalized medicine. The Future of Drug Discovery. 2013;231-248.
  65. 권순일. 맞춤의학시대를 열어갈 질환관련 SNP 연구의 최근 동향. 한국전문대학교육연구학회논문집, 2009;10(1):59-67.
  66. 식품의약품안전평가원. 의약품의 글로벌 개발.평가 동향. 2012:행정간행물번호: 11-1470550-000286-01.